Pediatric Vaccines Market
Pediatric Vaccines Market Size And Forecast
Pediatric Vaccines Market was valued at USD 25.8 Billion in 2018 and is projected to reach USD 56.4 Billion by 2026, growing at a CAGR of 10.3% from 2019 to 2026.
Global Pediatric Vaccines Market Outlook
Rising awareness regarding the benefits associated with vaccination in preventing diseases globally and several government and non-profit organizations providing education, funding and support services for vaccines are the factors that are augmenting the growth of the pediatric vaccines market. Moreover, the growing number of cases of hepatitis, influenza, bacterial and viral infection in infant, children and increasing birth rate globally is another factor anticipated to accelerate the market growth. The major restraining factor is stringent government regulations for approval process and high cost involved with the development of vaccines that might inhibit the market growth. Nonetheless, technological advancements and innovations focusing on development of pediatric vaccines with high efficiency and low cost is expected to create new opportunities for key market players.
Global Pediatric Vaccines Market Competitive Landscape
The Global Pediatric Vaccines Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Merck Sharp & Dohme Corp., GlaxoSmithKline plc., AstraZeneca, SANOFI, Pfizer, Inc., Zydus Cadila, Mitsubishi Tanabe Pharma Corporation, Indian Immunologicals Limited, Panacea Biotec, Serum Institute of India Pvt. Ltd.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.